Administration of catalase-loaded EVs in a 6-OHDA mouse model of PD reduced activated microglia compared to free catalase administration, suggesting that EV-based delivery of catalase has promise for restraining oxidative stress and neuroinflammation in PD [86]. Here, CAT is linked to Parkinson disease.